The MagicMed team has previously engaged with large industrial partners to develop new derivatives in other medicinal product markets, such as opiates and cannabinoids.

MagicMed partners will be able to search, select and test from the derivatives in the Psybrary™ and use them as a building block for their own product development based on the indication that they are targeting (anxiety, depression, addiction, PTSD and many others).

The MagicMed team will then continue to work with its partners to further refine and improve upon their selected derivative molecules to create finished medicinal product candidates and, in future, licit consumer products.

MagicMed’s partners potentially gain a significant edge over their competitors in new product development based on Psybrary™ molecules that are fully patent protected.

Once developed and approved, our Industry partners will sell products into medical and licit consumer markets.

MagicMed will work with partners post-development to monitor the market progress of the products produced in partnership with us to help them to continuously improve and expand.

Please send us a message to inquire about partnership opportunities.

Contact Us

Keep up with us on social.